Radiolabeled Mesoporous Silica Nanosystem Enables Long-Term Cell Tracking In Vivo
Molecular Pharmaceutics · 03.08.2026 · 23 (8) · 4217-4226
DOI: 10.1021/acs.molpharmaceut.6c00288 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 13.07.2026. Verfasst von Mengxin Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Beijing National Laboratory for Molecular Sciences, Cross-disciplinary Center for f-Elements (CCFE), Radiochemistry and Radiation Chemistry Key Labor…. Hauptthemen laut MEDLINE: Silicon Dioxide, Nanoparticles, Cell Tracking, Radioisotopes. Die Arbeit nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Ministry of Education of the People's Republic of China, Ministry of Science and Technology of the People's Republic of China.
Abstract (Originalsprache)
The clinical advancement of cell therapy necessitates precise in vivo tracking of functional cells, yet challenges persist in achieving this goal. Herein, we introduce zirconium-89 (89Zr)-labeled mesoporous silica nanoparticles (89Zr-mSiO2) as a robust platform for cell tracking via positron emission tomography (PET) imaging. The designed 89Zr-mSiO2 exhibits exceptional biocompatibility and internalization efficiency into cells, owing to its unique mesoporous structure and stable Si–O–Zr bonds. Both in vitro and in vivo studies demonstrate the prolonged stability and minimal cytotoxicity of 89Zr-mSiO2, ensuring reliable and safe cellular labeling. Notably, 89Zr-mSiO2 exhibits negligible cell efflux, enabling precise detection of cellular signals without interference. PET imaging of 89Zr-mSiO2-labeled cells in murine models allows for the real-time tracking of cell localization for up to 10 days postinjection. Overall, our findings highlight the potential of 89Zr-mSiO2 as a promising tool for long-term in vivo tracking of functional cells, thus advancing the prospects of cell therapy in a clinical setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing National Laboratory for Molecular Sciences, Cross-disciplinary Center for f-Elements (CCFE), Radiochemistry and Radiation Chemistry Key Laboratory of Fundamental Science, Key Laboratory of Bioorganic Chemistry a…
- Key Laboratory of Carcinogenesis and Translational Research of Ministry of Education, Key Laboratory for Research and Evaluation of Radiopharmaceuticals of National Medical Products Administration, Department of Nuclear…
- Peking University-Tsinghua University Center for Life Sciences, Peking University, Beijing100871, China.
- Department of Nuclear Technology and Application, China Institute of Atomic Energy, Beijing102413, China.
ORCID-Profile: Mengxin Xu, Zhibo Liu
Förderung
- National Natural Science Foundation of China
- Ministry of Education of the People's Republic of China
- Ministry of Science and Technology of the People's Republic of China
- Cancer Hospital, Peking University
- New Cornerstone Science Foundation
Zitieren
APA
Xu, M., Li, J., Li, J., Song, H., Chen, J., Liu, Y., Duan, D., & Liu, Z. (2026). Radiolabeled Mesoporous Silica Nanosystem Enables Long-Term Cell Tracking In Vivo. Molecular Pharmaceutics, 23(8), 4217-4226. https://doi.org/10.1021/acs.molpharmaceut.6c00288
Vancouver
Xu M, Li J, Li J, Song H, Chen J, Liu Y, et al. Radiolabeled Mesoporous Silica Nanosystem Enables Long-Term Cell Tracking In Vivo. Molecular Pharmaceutics. 2026;23(8):4217-4226. doi:10.1021/acs.molpharmaceut.6c00288
BibTeX
@article{Xu2026,
author = {Xu, Mengxin and Li, Jiangsheng and Li, Jiaqi and Song, Hanbo and Chen, Junyi and Liu, Yu and Duan, Dongban and Liu, Zhibo},
title = {Radiolabeled Mesoporous Silica Nanosystem Enables Long-Term Cell Tracking In Vivo},
journal = {Molecular Pharmaceutics},
year = {2026},
volume = {23},
number = {8},
pages = {4217--4226},
doi = {10.1021/acs.molpharmaceut.6c00288}
}
EUVIMED